Alto Neuroscience, Inc.
ANROPharmaceutical Preparations · SIC 2834 · CIK 0001999480
Revenue FY2025
—
Net Income
$(63.0M)
EPS (Basic)
$-2.19
Net Margin
—
ROE
-41.8%
Total Equity
$151.0M
Shares Out
39M
Alto Neuroscience, Inc. — Pharmaceutical Preparations. Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2023–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.
Revenue & Net Income (10Y)
Margin Trends
Investor Ownership · 4 funds in our universe
Insider Transactions
Reading stored insider transactions…